A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)

NCT00796367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

676

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: VI-0521
DRUG: Placebo
DRUG: VI-0521

Sponsor

VIVUS LLC

Collaborators

[object Object]